Biomed start-up Hummingbird Bioscience opens new facility to boost its R&D work

September 23, 2022 4:34 PM

SINGAPORE – Singapore-based biomedical start-up Hummingbird Bioscience, which specialises in developing antibodies for cancer treatment, on Friday launched a new facility to expand its scientific, and research and development capabilities.